Inventor profile of:

Michael Sierks

City:

Ft. McDowell, Arizona

Country:

United States

Published Applications:

27

Last publication date:

2025-03-13

Top Assignees for applications by Michael Sierks

The entities that hold a legal rights for patent applications filed by inventor Sierks Michael:

Recent patent applications by Sierks Michael

Michael Sierks from Ft. McDowell, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-13
US20250084157A1
Chemistry; metallurgy

ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE TOXIC OLIGOMERIC FORMS OF TAU

#2 | 2024-09-12
US20240301042A1
Chemistry; metallurgy

SELECTIVE TARGETING OF OLIGOMERIC B-AMYLOID

#3 | 2022-09-01
US20220276264A1
Physics

DARPin REAGENTS THAT DISTINGUISH ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE SAMPLES

#4 | 2022-08-18
US20220260593A1
Physics

TARGETS AND METHODS OF DIAGNOSING, MONITORING AND TREATING FRONTOTEMPORAL DEMENTIA

#5 | 2022-07-14
US20220221795A1
Physics

METHODS FOR DETECTING TRAUMATIC BRAIN INJURY

#6 | 2021-12-02
US20210373036A1
Physics

Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein TDP-43

#7 | 2021-10-21
US20210324060A1
Chemistry; metallurgy

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

#8 | 2020-09-24
US20200299367A1
Chemistry; metallurgy

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

#9 | 2020-09-03
US20200278358A1
Physics

METHOD OF DISTINGUISHING BETWEEN DIFFERENT NEURODEGENERATIVE DISEASES

#10 | 2020-07-30
US20200241014A1
Physics

DARPin reagents that distinguish Alzheimer's disease and Parkinson's disease samples

#11 | 2019-08-15
US20190250171A1
Physics

Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein TDP-43

#12 | 2019-06-27
US20190195892A1
Physics

METHOD OF DISTINGUISHING BETWEEN DIFFERENT NEURODEGENERATIVE DISEASES

#13 | 2019-06-20
US20190185553A1
Chemistry; metallurgy

ANTIBODY BASED REAGENT THAT SPECIFICALLY RECOGNIZES TOXIC OLIGOMERIC FORM OF BETA-AMYLOID

#14 | 2018-12-20
US20180364577A1
Physics

Methods for detecting traumatic brain injury

#15 | 2018-10-18
US20180298086A1
Chemistry; metallurgy

ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE TOXIC OLIGOMERIC FORMS OF TAU

#16 | 2017-07-20
US20170205431A1
Physics

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

#17 | 2017-07-20
US20170204170A1
Chemistry; metallurgy

ANTIBODY BASED REAGENT THAT SPECIFICALLY RECOGNIZES TOXIC OLIGOMERIC FORM OF BETA-AMYLOID

#18 | 2017-01-12
US20170010284A1
Physics

Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein TDP-43

#19 | 2016-11-03
US20160320412A1
Physics

METHOD OF DISTINGUISHING BETWEEN DIFFERENT NEURODEGENERATIVE DISEASES

#20 | 2016-10-06
US20160291037A1
Physics

METHODS FOR DETECTING TRAUMATIC BRAIN INJURY

#21 | 2016-04-14
US20160102140A1
Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES

#22 | 2015-09-24
US20150266947A1
Chemistry; metallurgy

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

#23 | 2015-02-26
US20150056638A1
Chemistry; metallurgy

Nanoscale process to generate reagents selective for individual protein variants

#24 | 2014-02-13
US20140044733A1
Chemistry; metallurgy

Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloid

#25 | 2014-01-09
US20140011691A1
Physics

MORPHOLOGY AND PROTEIN SPECIFIC REAGENTS AS DIAGNOSTICS FOR NEURODEGENERATIVE DISEASES

#26 | 2013-10-31
US20130287800A1
Human necessities

Immunization with amyloid-beta oligomers

#27 | 2012-09-13
US20120230999A1
Chemistry; metallurgy

Bispecific nanobodies as a therapeutic for alzheimer's disease

InventorID:

507669 ⎘